Log in to save to my catalogue

The diagnostic impact of fractional exhaled nitric oxide for asthmatic cough in nontuberculous mycob...

The diagnostic impact of fractional exhaled nitric oxide for asthmatic cough in nontuberculous mycob...

https://devfeature-collection.sl.nsw.gov.au/record/TN_cdi_doaj_primary_oai_doaj_org_article_94c9ddcc021f42ef9728bfab8c00de45

The diagnostic impact of fractional exhaled nitric oxide for asthmatic cough in nontuberculous mycobacterial pulmonary disease

About this item

Full title

The diagnostic impact of fractional exhaled nitric oxide for asthmatic cough in nontuberculous mycobacterial pulmonary disease

Publisher

England: BioMed Central Ltd

Journal title

BMC pulmonary medicine, 2024-04, Vol.24 (1), p.210-210, Article 210

Language

English

Formats

Publication information

Publisher

England: BioMed Central Ltd

More information

Scope and Contents

Contents

Measurement of exhaled nitric oxide (FeNO) is a potentially useful diagnostic test for asthma. However, no study has explored the relationship between FeNO and respiratory symptoms of nontuberculous mycobacterial pulmonary disease (NTM-PD) complicated with asthma. The objective of this study was to assess the utility of measuring FeNO levels in pat...

Alternative Titles

Full title

The diagnostic impact of fractional exhaled nitric oxide for asthmatic cough in nontuberculous mycobacterial pulmonary disease

Identifiers

Primary Identifiers

Record Identifier

TN_cdi_doaj_primary_oai_doaj_org_article_94c9ddcc021f42ef9728bfab8c00de45

Permalink

https://devfeature-collection.sl.nsw.gov.au/record/TN_cdi_doaj_primary_oai_doaj_org_article_94c9ddcc021f42ef9728bfab8c00de45

Other Identifiers

ISSN

1471-2466

E-ISSN

1471-2466

DOI

10.1186/s12890-024-03028-3

How to access this item